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Abstract
Background: Information and communication technology (ICT) has made remarkable progress in recent years and is being
increasingly applied to medical research. This technology has the potential to facilitate the active involvement of research
participants. Digital platforms that enable participants to be involved in the research process are called participant-centric initiatives
(PCIs). Several PCIs have been reported in the literature, but no scoping reviews have been carried out. Moreover, detailed
methods and features to aid in developing a clear definition of PCIs have not been sufficiently elucidated to date.
Objective: The objective of this scoping review is to describe the recent trends in, and features of, PCIs across the United States,
the United Kingdom, and Japan.
Methods: We applied a methodology suggested by Levac et al to conduct this scoping review. We searched electronic
databases—MEDLINE (Medical Literature Analysis and Retrieval System Online), Embase (Excerpta Medica Database), CINAHL
(Cumulative Index of Nursing and Allied Health Literature), PsycINFO, and Ichushi-Web—and sources of grey literature, as
well as internet search engines—Google and Bing. We hand-searched through key journals and reference lists of the relevant
articles. Medical research using ICT was eligible for inclusion if there was a description of the active involvement of the
participants.
Results: Ultimately, 21 PCIs were identified that have implemented practical methods and modes of various communication
activities, such as patient forums and use of social media, in the field of medical research. Various methods of decision making
that enable participants to become involved in setting the agenda were also evident.
Conclusions: This scoping review is the first study to analyze the detailed features of PCIs and how they are being implemented.
By clarifying the modes and methods of various forms of communication and decision making with patients, this review contributes
to a better understanding of patient-centric involvement, which can be facilitated by PCIs.
International Registered Report Identifier (IRRID): RR2-10.2196/resprot.7407
(J Med Internet Res 2020;22(8):e16441) doi: 10.2196/16441
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The use of information and communication technology (ICT)
is increasing in all aspects of health care delivery and medical
research, enabling vast amounts of data to be accumulated and
analyzed at an unprecedented rate. Furthermore, a growing
number of people are participating in research using smart
devices, such as smartphones, tablets, and wearable devices [1].
Participation in medical research using ICT is expected to
increase in the future. At the same time, patient-reported
outcomes, where the patient reports directly on his or her
condition, such as pain, fatigue, and quality of life, are
recognized as important for both clinical and research settings
[2,3]. This new trend in medicine also facilitates the use of ICT
in the medical research fields.
In parallel, attitudes toward medical research are also shifting
to more active involvement of research participants. This
emerging model of research, in which researchers and
participants collaborate through the research process, is gaining
momentum internationally. Several research funders, such as
INVOLVE in the United Kingdom, which was established by
the National Institute for Health Research (NIHR) to support
public involvement in the National Health Service (NHS), and
the Patient-Centered Outcomes Research Institute (PCORI) in
the United States, are known as leading organizations promoting
the involvement of research participants [4].
The definition of patient and public involvement and
engagement has not yet been established. There is no designated
terminology to describe the active involvement of participants
in research. According to INVOLVE, involvement is defined
as “research that is being carried out ‘with’ or ‘by’ members of
the public, rather than ‘to,’ ‘about,’ or ‘for’ them,” while
engagement indicates “information and knowledge about
research is provided and disseminated” [5]. On the other hand,
PCORI in the United States uses the term engagement in the
following way: “The meaningful involvement of patients,
caregivers, clinicians, and other healthcare stakeholders
throughout the entire research process” [6]. Another example
of the fluidity of the terminology can be seen in a consensus
statement on patient and public involvement with data-intensive
health research, which was developed by an international group
of experts; they use the term public involvement and engagement
[7]. While the terminology may change, a shared sentiment in
all these documents is that they define patients or the public as
experts in their personal knowledge and experiences.
Collaborating with patients and the public is expected to improve
research quality and relevance, ensure transparency and
accountability, and foster innovation and research [5-9].
In this review, we use the definition from INVOLVE [5], where
involve or involvement refers to a status where participants play
an active role in medical research, beyond the level of simply
being a participant to take part in research or inputting their
data [10]. For instance, we hoped to find examples where
participants collaborate with researchers and have influence
over research design, analysis, management, and/or
dissemination. While recognizing the diversity of approaches
to involvement, here, we are not including activities such as the
raising of awareness of research by patients or the creation of
events, such as workshops and festivals to engage with the
public [11].
Participant-centric initiatives (PCIs) are new initiatives that
employ ICT for facilitating active involvement in research and
are defined as “digital tools, platforms, or projects that have
been developed to help participants become more actively
involved in the research process” [12]. PCIs have the potential
to provide a number of benefits to both participants and
researchers, including facilitating participant recruitment and
retention, providing the basis for long-term partnerships, and
sustaining public confidence in research [13]. In addition to
this, the interactive interface facilitates communication between
research participants and researchers throughout the research
process and allows participants to be placed at the center of the
decision-making process [13]. Furthermore, it is believed that
PCIs can address issues toward protecting individual interests
by mediating participants’ control and choice within diverse
research contexts [12].
While examples and features of PCIs have been reported by
Anderson et al [12] and Kaye et al [13], in 2012, the definition
of PCIs and methods of involvement that are promoted through
PCIs had not yet been established. Moreover, the status and
characteristics of PCIs since they were first outlined in these
papers have not been reported. We believed that it was important
to capture the current landscape of PCIs and describe detailed
characteristics and methods of participant involvement.
By applying a scoping review methodology, we examined PCIs
that have been implemented in the United States, the United
Kingdom, and Japan, and we systematically analyze their
detailed functions and features. The reason for selecting these
countries for the study was that the United States and the United
Kingdom have been actively advancing patient-centric
approaches in medical research, and the majority of reported
PCIs in previous research was located in these two countries
[12,13]. Our aim was to build on the existing research by
updating the PCI landscape for the United Kingdom and the
United States and by further contributing to the literature by
adding Japan. Japan is a leading country in health research and
practice, and we were well positioned to access the literature.
While a traditional model of medical research remains pervasive
in Japan [14], there is a clear shift toward exploring or
prioritizing patient and public involvement, as seen in recent
statements made by the Japan Agency for Medical Research
and Development, a major medical funding agency [15]. Given
this new focus, it was timely to search and explore the current
landscape of PCIs available in Japan. We felt that focusing our
attention on these three countries would make an important
contribution to the literature on PCIs.
Therefore, the aims of this study were (1) to identify existing
PCIs used for medical research in the United States, the United
Kingdom, and Japan, (2) to describe recent trends and features
of PCIs, and (3) to highlight the methods of participant
involvement facilitated by PCIs.
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The methodology followed here is based on the previously
published study protocol [16]. The scoping review was
considered the most appropriate method to address the aims of
the study for the following reasons. Firstly, the scoping review
is recommended, as it is particularly relevant to disciplines with
emerging evidence [17]. Unlike a systematic review, we are not
trying to answer a specific question, but rather “examine the
extent, range, and nature” of PCIs [18]. Secondly, a scoping
review provides comprehensive search methods to incorporate
a range of study designs in both published and grey literature.
The scoping review methodological framework described by
Levac et al [17] was applied to this study.
Identifying the Research Question
According to the features of PCIs described by Anderson et al
[12], it is not necessary to designate the field of research upfront,
but we decided to limit our study to PCIs generating data for
medical research. In addition, citizen science, which we define
here as a research activity directed and conducted by citizens
without collaboration with researchers, was considered beyond
our remit [19]; therefore, we focused on interaction between
participants and researchers using PCIs.
In this study, medical research refers to any research involving
human subjects aimed at improving clinical outcomes, including
prevention; understanding the etiology of diseases and/or effect
of treatments; and improving the quality of life of patients.
Identifying Relevant Studies
We first conducted a literature search in June 2017 in the
following databases: MEDLINE (Medical Literature Analysis
and Retrieval System Online), Embase (Excerpta Medica
Database), CINAHL (Cumulative Index of Nursing and Allied
Health Literature), PsycINFO, and Ichushi-Web. We conducted
our search by using subject headings and keywords. Search
terms included a combination of keywords and subject headings
such as Medical Subject Headings (MeSH). Keywords were
comprised of the following terms: “participant” AND “centric”
OR “centered” OR “centred” OR “engage” OR “involve” OR
“collaborat” OR “partner” OR “led” OR “driven” OR “initiat”
OR “oriented.” Subject headings for “participation,”
“technology,” and “research” were searched and adjusted to
best meet the requirements of each database. The detailed search
strategies and history are shown in Multimedia Appendix 1. A
subject librarian was consulted and provided guidance on the
search strategy. We also conducted a cited literature search
using the Web of Science and by hand-searching of key
journals—Digital Health and The Journal of mHealth—in
August 2017.
A grey literature search was also conducted using Open Grey
in December 2017, and a website search was conducted using
Google and Bing from April to June 2018. The grey literature
and website searches were conducted by using the same search
keywords as in the literature database search. Some searches
showed a large number of items, for example, more than 100,000
hits. However, as it was practically challenging to identify
relevant websites by screening all items, we took a pragmatic
approach and screened websites that had appeared within the
first 50 results for each keyword.
Study Selection
The relevant articles and websites were screened based on the
inclusion criteria described in Textbox 1. These criteria were
formulated based on the description of the PCIs [12,13], and
some criteria were added by the research team in the process
of screening. The articles obtained by the database search were
screened by two independent reviewers (NH and RN), and PCIs
were identified from this process. The items identified from the
grey literature and website searches were screened by NH, and
the selection was confirmed by the research team after several
rounds of discussion on the screening results.
Textbox 1. Selection criteria for relevant articles and websites.
Inclusion criteria:
• Research enables participants to become actively involved in the research design
• Complies with participant-centric initiative (PCI) features described by Anderson et al [12]: (1) digital device or tool, computer program, or
digital platform, and (2) projects that empower participants to engage in the research process
• Articles, documents, or websites published in English or Japanese
• Adult population (ie, over 18 years of age)
• Focuses on medical research purposes
• Available to participants in the United States, the United Kingdom, or Japan
Exclusion criteria:
• Platforms that enable patients to connect and communicate with other patients only
• Platforms that use data for research, but there is no interaction between participants and researchers
• Research activity directed and conducted by citizens without the support of scientists
• Research intended to improve the efficiency of clinical practices or to develop tools for health care services
• Medical research that aims to engage with participants without using a digital platform
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The features of PCIs were extracted and mapped from the
relevant articles and information on the websites of each PCI.
The data extraction was completed by NH, and the preliminary
results were reviewed by research study members to ensure
validity. Characteristics to extract included the following:
characteristics of PCI websites, type of medical research, and
method of involvement. The list of data elements that were
extracted are shown in Multimedia Appendix 2.
Collating, Summarizing, and Reporting the Results
The PRISMA (Preferred Reporting Items for Systematic
Reviews and Meta-Analyses) flowchart template [20] was
applied to report on the search process. The key characteristics
of the included PCIs were summarized in results tables and
charts. The key findings were described in a summary report
before disseminating to expert panel members.
Consultation With Expert Panel
A consultation is recommended as an optional stage in
conducting a scoping review [17]. We carried out a consultation
in January 2019 with a small number of experts to receive
feedback about the obtained results, including additional
information and perspectives. Using our research network, the
expert panel included four researchers and a patient
representative with expertise in patient and public involvement,
health care and digital technologies, and clinical cohort studies
from the United States, the United Kingdom, Australia, and
Japan.
Results
Identifying Relevant Studies and Study Selection
The search results and screening process are shown in Figure
1. The screening process can be divided into two flowcharts:
the database search and the grey literature search.
In the database search, 10 relevant articles [1,12,13,21-27]
remained after the title, abstract, and full-text screening, and
the descriptions of 13 potential PCIs were found in those papers.
Within these 13 potential PCIs, 3 had been implemented in
nontargeted countries (ie, Italy, the Netherlands, and Iceland),
and 3 websites were not accessible, possibly due to the
termination of the projects. Only 1 website focused on releasing
personal genetic data openly to the public; we considered this
beyond the inclusion criteria of this scoping review because all
participants were scientists, and they were not aiming at
collaborating with patients or citizens. As a result, 6 PCIs
satisfying the inclusion criteria were identified in the database
search.
The grey literature and website searches were conducted in an
iterative process reflecting the results of the database search
that had been performed earlier. In total, 3622 documents and
websites were screened, but none described the implementation
of PCIs for medical research. However, 16 additional PCIs were
identified by a supplementary search of 2 excluded articles
[28,29] from the database search. Both articles were related to
the PCORI. Another 2 potential PCIs were discovered while
searching for information on other PCIs that had been found in
the database search. In total, 16 PCIs were identified in the
website search. After removing duplicates, 21 PCIs [30-50]
were ultimately identified in the obtained results (see Table 1).
The detailed characteristics of these 21 PCIs are also shown in
Multimedia Appendix 3.
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Figure 1. Flowchart for study selection. MEDLINE: Medical Literature Analysis and Retrieval System Online; Embase: Excerpta Medica Database;
CINAHL: Cumulative Index of Nursing and Allied Health Literature; PCI: participant-centric initiative.
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Table 1. Participant-centric initiatives (PCIs) identified by our scoping review.
Number of usersaLaunch yearAreas of focusType of organizationLocationName of PCINo.
>1,200,0002006Diverse (more than 230)IndustryUnited
States
23andMe [30]1














































































aThe number of registrants (ie, users) is based on information publicly available in July 2018.
bPEER: Promise for Engaging Everyone Responsibly.
cNPO: nonprofit organization; includes patient organizations and research organizations.
dRUDY: Rare and Undiagnosed Diseases Study.
eIBD: Inflammatory Bowel Disease.
fCOPD PPRN: Chronic Obstructive Pulmonary Disease Patient-Powered Research Network.
gIAN: Interactive Autism Network.
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hAD-PCPRN: Alzheimer's Disease Patient- and Caregiver-Powered Network.
iPI: Primary Immunodeficiency.
jV-PPRN: Vasculitis Patient-Powered Research Network.
Difficulties in Searching for Relevant Studies
During the database search, it became clear that there were no
designated subject headings to describe features of the PCIs
within this emerging field; for instance, the existing MeSH do
not have terms to include “participant-centric,” “engagement,”
or “involvement”; alternatively, “patient participation” was
suggested as the only MeSH option. The subject heading is
typically used as an effective search tool in a database search.
In this case, however, we had to combine keywords to search
for articles relevant to PCIs. The lack of effective search terms
may reflect the novelty of the field. For the same reason, the
results of grey literature and website searches using Google and
Bing were also limited.
Many of the documents that were excluded in the screening
process were related to patients’decision making or participation
in clinical practice or medical interventions, including test
screening, rather than medical research. Another major category
of excluded items concerned the digitization of research and
health care with the aim of developing tools for services, with
no description of the involvement of participants.
Results of the Expert Panel
After the consultation, all members of the expert panel
commented on the obtained results. Overall, they considered
the results “important and well worthy of publication” and the
search strategy as “sensible.” In addition, the experts gave
feedback on the analysis and discussion sections of the paper.
The feedback was incorporated into our analysis of results and
the discussion.
There were also suggestions on potential PCIs we had not
identified through the literature search. A total of 5 potential
platforms were suggested by two members of the panel—one
from Japan and one from the United Kingdom. Moreover, one
member suggested that disease registries were underrepresented
in the obtained results. The main reasons that we did not pick
up these registries with our literature search is that any scientific
papers generated by them appeared after our cutoff point or they
did not indicate active involvement of patients in existing papers.
In response, we screened the registries listed on the National
Institutes of Health (NIH) website. A total of 62 registries were
screened by NH and AK. As a result, we identified 5 PCIs in
the United States and Japan, which had not come out in our
original literature search. Moreover, an anonymous reviewer
suggested an additional PCI during the peer-review process. As
we had decided that the results of the literature searches would
be our endpoint for this study, these additional PCIs are offered
here as supplementary data (see Multimedia Appendix 4). It is
noteworthy, however, that the features of these PCIs do not
change the overall landscape we describe as the main endpoint
of the study.
Recent Trends in PCIs
PCIs have been implemented for research focusing on various
diseases, including rare diseases, mood disorders, heart diseases,
and dementia. Of the 21 kinds of PCIs identified in this scoping
review, 4 (19%)—23andMe, PatientsLikeMe, PEER (Promise
for Engaging Everyone Responsibly), and
GenomeConnect—had features that included a variety of disease
areas and had cross-cutting registry functions ranging from
dozens to thousands of diseases. One of them was a
direct-to-consumer genetic testing company (ie, 23andMe). In
these PCIs, multiple kinds of medical research were being
conducted. Furthermore, these 4 PCIs aimed to match the
genomic information of research participants with their disease
phenotype. On the contrary, the main registration objectives of
the other 17 PCIs for medical research concerned specific
disease areas; some of them had gradually expanded their
disease areas of focus, such as RUDY (Rare and Undiagnosed
Diseases Study) and V-PPRN (Vasculitis Patient-Powered
Research Network).
Examining the year in which each PCI was established, our
results show a dramatic upward trend from 2013 onwards (see
Figure 2).
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Figure 2. The trend in the number of participant-centric initiatives (PCIs) identified in the scoping review, cumulative total by year. NB: For 2 PCIs,
the launch year was unknown.
Medical Research Facilitated by PCIs
The medical research conducted using digital tools, such as
personal computers and smartphones, had one or both of the
following purposes:
1. Understanding the symptoms: changes in the presentation
of symptoms over time, genetic information and disease
phenotype matching, daily changes of conditions, and health
conditions associated with everyday life, including exercise
and diet.
2. Comparison of treatment effectiveness: a case-control study
comparing the effects of interventions, such as comparing
medication records with symptoms or the impact of an
online exercise class.
We found that at least 277 articles had already been published
by several PCI research groups by January 2018, including some
in major scientific journals [33-36,40,50-52]. Among them,
PatientsLikeMe and 23andMe are promoting research covering
various disease areas and have published more than 100 papers
[51,52]. All PCIs were used to facilitate participation in
substudies or provide opportunities to join upcoming research.
Table 2 shows the specific data collected by each PCI. Overall,
the majority of PCIs had analyzed questionnaires on symptoms
and quality of life. Functions to upload the results of DNA
testing and electronic health record data were also implemented
in 7 PCIs, corresponding to one-third of the total. Other
functions included tracking personal data, such as body
temperature, blood pressure, and weight. A total of 3 PCIs had
an interface to collect data using new functions on smartphones
and wearable devices, such as those relating to movement and
voice.
Table 2. Types of data collected by participant-centric initiatives (PCIs).
Number of PCIs (N=21), n (%)Types of data
7 (33)DNA test result
17 (81)Closed-ended questionnaire
5 (24)Open-ended questionnaire
16 (76)Treatment and medication
3 (14)Motion and voice
4 (19)Self-reported measurement
5 (24)aElectronic health record
aIn addition to the 5 PCIs that collected electronic health record data, 2 were in preparation.
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Model of Informed Consent
Table 3 shows the result of consent models that were indicated
on each of the websites. A specific consent model—a
participant’s consent is requested each time they participate in
a new study—was used for approximately half the PCIs (12/21,
57%). On the contrary, a broad consent model was used in 1
PCI (5%) that was developed by a for-profit organization (ie,
PatientsLikeMe).
In total, 3 PCIs out of 21 (14%)—PEER, RUDY, and
J-RARE—implemented a dynamic consent model. Dynamic
consent is a new model that enables participants to change their
consent status over time online [53]. Furthermore, participants
can also select the range of data sharing and methods of
communication. There were 5 PCIs out of 21 (24%) where the
consent process was unclear.
Table 3. Model of consent implemented in participant-centric initiatives (PCIs).




16 (76)Treatment and medication
3 (14)Unknown
Various Communication Activities
By examining the activities undertaken by the 21 PCIs, it
became clear that various modes of communication had been
used, including patient forums, webinars, and dialogue (ie,
patients and researchers exchanging messages online) (see Table
4). Moreover, a majority of the PCIs had used multiple social
media accounts. Some PCIs had disseminated information
through blogs and newsletters. Others had their own digital
interface that allowed participants to take part in networking
with researchers and other participants. Out of 21 PCIs, 2 (10%)
had been conducting face-to-face forums or seminars.
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Table 4. Modes and methods of communication for the participant-centric initiatives (PCIs).
Other modes of commu-
nication













































aIncluded community day, leadership summit, and research forum.
bIncluded content for general use.
cIncluded the sharing of experiences, thoughts, and information with researchers and other patients; networking.
dPEER: Promise for Engaging Everyone Responsibly.
eMOSAIC: Model of Observational Screening for the Analysis of Interaction and Communication.
fRUDY: Rare and Undiagnosed Diseases Study.
gN/A: not applicable.
hGAP: Generate, Assess, Prioritize, Plan, Perform, and Publish.
iIBD: Inflammatory Bowel Disease.
jCOPD PPRN: Chronic Obstructive Pulmonary Disease Patient-Powered Research Network.
kIAN: Interactive Autism Network.
lAD-PCPRN: Alzheimer's Disease Patient- and Caregiver-Powered Network.
mPI: Primary Immunodeficiency.
nV-PPRN: Vasculitis Patient-Powered Research Network.
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Participant Decision Making in Various Research
Processes
It became clear that there were various phases in decision
making by research participants. First, the 3 PCIs that
implemented the dynamic consent model allowed each
participant to control the range of data sharing. Most PCIs used
an interface that enabled inputs of participant feedback on
research and operations or agenda setting by allowing
participants to propose new research questions. Furthermore,
more than half the PCIs (14/21, 67%) had a governance structure
that included participant representatives in the decision-making
process of the research design and conduct of the research (see
Table 5).
Table 5. Decision-making process implemented in participant-centric initiatives (PCIs).
Research design and
governanceb


























aIndividual comments, suggestions of research questions, decisions of priority, etc.
bThe main purpose is to determine the overall policy as representative of research participants, such as an advisory board, a steering committee, and a
governor group.
cPEER: Promise for Engaging Everyone Responsibly.
dRUDY: Rare and Undiagnosed Diseases Study.
eIBD: Inflammatory Bowel Disease.
fCOPD PPRN: Chronic Obstructive Pulmonary Disease Patient-Powered Research Network.
gIAN: Interactive Autism Network.
hAD-PCPRN: Alzheimer's Disease Patient- and Caregiver-Powered Network.
iPI: Primary Immunodeficiency.
jV-PPRN: Vasculitis Patient-Powered Research Network.
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In this study, we conducted a scoping review to capture the
recent trend and features of PCIs for medical research, in
particular, by focusing on active involvement. A total of 21
PCIs were identified by the scoping review. After analyzing the
detailed functions and characteristics of each, the landscape of
PCIs became clearer. To our knowledge, this is the first scoping
review conducted in this emerging area to map the extent and
range of PCIs currently available across the United States, the
United Kingdom, and Japan.
Recent Trends in PCIs
The PCIs identified in this study were utilized in medical
research in various fields. The number of participants registered
for each PCI ranged from approximately 50 to 100,000 (see
Table 1). Moreover, it was revealed that there are two types of
PCIs in terms of target population and research purpose. A total
of 4 PCIs targeted dozens or more diseases, aimed at
understanding the relationship between genomic information
and clinical phenotype. On the contrary, the other 17 PCIs
targeted specific disease areas with the aim of deepening clinical
understanding of the symptoms. In addition, PCIs connect
participants and researchers with opportunities to join in
different medical research studies. Regarding the significant
number of participants and the broad targets of research, it is
evident that ICT interfaces provide effective ways to promote
research without the limitations of conducting research in real
time and geographic area.
Another noteworthy trend was the sharp increase in the number
of PCIs after 2013. The reasons for the increase may be
improvements in technology and greater understanding of the
benefits of using digital technologies in health care, as well as
an increasing awareness of the importance of engaging with
patients. As 12 of the 21 PCIs (57%) were funded by PCORI
in the United States, the trend may also have been influenced
by the year of its establishment. PCORI was established in 2010
with the aim of funding comparative clinical effectiveness
research for patients and those who care for them to make
better-informed health decisions [54]. Moreover, PCORI
promotes patient engagement to ensure that results are relevant
and useful to stakeholders [55,56]. Meanwhile, various factors,
such as an increased research focus on patient-reported outcomes
[57] and more medical research using smartphones and wearable
devices [58], are also thought to be related to this recent trend
in PCIs.
There are at least 270 scientific papers published that used data
collected by PCIs. Out of 21 PCIs, 2 (10%)—23andMe and
PatientsLikeMe—are notable because they have published
nearly 100 papers in the area between them; both are organized
by for-profit organizations. It is necessary to analyze them
further to understand the kinds of research papers that are
published by these PCIs and why these for-profit organizations
seem to have a greater reach than others.
Features of PCIs
The features of PCIs have been described in a prior paper [13]
as “placing participants in control; using social media
technology; promoting active participation; facilitating
communication; appealing to public good.” With the results of
this scoping review, these features have become clearer.
Dynamic consent was implemented in 3 out of 21 PCIs
(14%)—PEER, RUDY, and J-RARE—while 12 PCIs (57%)
implemented the specific consent model. This result indicates
that not all PCIs embedded individual control into the design
of the interface.
The use of social media technology, such as information
dissemination, was observed in most of the 21 PCIs. This allows
participants to see the progress in research and the results. PCIs
also generally provide user-friendly platforms that facilitate
two-way interaction between participants and researchers and,
in some PCIs, between the participants. In more than half of
the 21 PCIs, participants were involved in suggesting research
questions. These results indicate that PCIs enable participants
to play an active role, not only in terms of controlling their own
data-sharing settings but also by way of contributing to decision
making in research design. They encourage participants to
become involved in the agenda setting of the entire research
community. A follow-up study is needed to examine the method
and evaluation of these involvement activities.
Definition of PCIs
The definition of PCIs was suggested in prior studies in 2012
[12,13], as described in our introduction. However, while
conducting this scoping review, we initially found it difficult
to distinguish PCIs from other related digital platforms. By
analyzing the obtained results, the essential concept and features
of PCIs became clearer. Therefore, in this study, we
reconsidered the definition of PCIs with clearer and more
rigorous criteria. Our proposed updated definition of PCIs is as
follows: (1) research activities use ICT, (2) participants are
actively involved in the agenda setting of research, and they
play roles beyond those of research subjects or assistants, (3)
participants can communicate with researchers interactively
throughout the research process, and (4) participants can choose
the level of their involvement.
PCIs cultivate an environment to establish collaborative
partnerships between participants and researchers. As this
participant-centric model is still emerging, the number of PCIs
that are currently in practice is small, compared with other kinds
of medical research that uses ICT. Employing a rigorous criteria
of patient involvement, we excluded researcher-led initiatives
that aim at collecting data, such as many patient registries and
disease registries, because they did not indicate active
involvement by patients either on their website or in their
published literature. We also excluded patient registries created
with the active support of patient organizations if that
involvement was limited to recruiting patients to provide data.
Moreover, research projects that limit patient involvement to
communicating with participants to disseminate information or
to respond to inquiries were also excluded, as we did not
consider this to be interactive communication. Clarifying
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exclusions and inclusions as part of the screening process also
allowed us to clearly identify the distinctive levels of
involvement and the features of PCIs.
Comparison Between PCIs in the United States, the
United Kingdom, and Japan
Of the 21 PCIs identified, 19 (90%) were initiated in the United
States. There may be a number of possible reasons for this,
some of which suggest avenues for future investigation. Firstly,
it is possible that the culture of involving patients and members
of the public in research is more established in the United States.
Our results indicated that many of the PCIs were funded by
PCORI. The Patient-Powered Research Network is one of the
research networks that is operated and governed by patient
groups, and it has launched a number of projects using online
platforms to collect self-reported data [55,56]. This may suggest
that differences in policies of funding organizations have
influenced the number of PCIs among the three countries. In
the United Kingdom, research funding bodies, such as the
Medical Research Council (MRC) and the NIHR, require all
applicants to state how they will involve patients and members
of the public in the design of the research study, which suggests
the culture for patient involvement in medical research is also
reasonably well established in the United Kingdom.
Nevertheless, this has not yet translated into the establishment
of PCIs. Indeed, we found only one funded research project that
was using a digital platform.
Furthermore, the differences in the way that health care is
organized may be an additional explanatory factor, but this
would need further exploration. The US system is rather unique
in the way it organizes health care and this may be tied into the
more populous PCI landscape in the country. We are aware that
patients in the United States are often engaged around social
entrepreneurship in health care and play key roles in initiating
new research projects [59]. There may also be different attitudes
between the three countries toward the utilization of ICT and
direct-to-consumer services. Another consideration is the
population size. Although the explanatory power is probably
somewhat weak, the larger number of PCIs in the United States
may, in part, reflect the much larger population size compared
to Japan and the United Kingdom.
Future research is needed to disentangle the factors impacting
the establishment and sustainability of PCIs in order to better
understand the underlying reasons for the differences between
these countries.
Limitations and Future Challenges
In this paper, we investigated PCIs, which enable the active
involvement of patients, by conducting a scoping review to
understand this new field that has not yet been conceptually
established. Therefore, there are a number of limitations to this
work.
First, due to limitations in the search method, some PCIs might
have been overlooked in our search. For example, any
PCI-related documents that do not contain our keywords
indicating active involvement of patients in the titles or abstracts
would have been extremely difficult to detect. This would also
hold for the website search results. We suggested that consistent
definition and terminology of participant involvement should
be established to overcome these methodological limitations.
Second, any PCIs that do not publish their research in scientific
articles, or those whose websites do not appear in any search
engine results, would not have been found. Further, research
articles and websites that were published after our search period
would also have not been included in our findings.
For future research, PCIs implemented in countries other than
those focused on in this study also deserve attention. For
instance, other English-speaking countries, such as Canada,
Australia, and New Zealand, where there is a push toward
patient and public involvement in medical research could be
prioritized in future research. Furthermore, it may be desirable
to seek a method to evaluate PCIs by a variety of means, such
as careful observation, surveys of participant opinions, and
exploration of theoretical considerations. Such results will offer
insights to further improve ongoing PCIs and aid the
establishment of new ones in the future.
We can also propose possible ideas for moving forward the area
of PCIs. In this review, we have documented the important
activities of PCIs; at the same time, we have noted that there
are still only a small number of projects that meet the criteria
we have set for patient involvement. Therefore, the future
challenge in the field is how to expand the number of PCIs and
also the level of patient involvement that these platforms enable.
Ideas for improvement can include the following: (1) wider
dissemination of information about the value of PCIs for patients
and patient organizations, (2) encouragement of networking
between PCIs to facilitate the adoption of good practices, and
(3) increase of support by government bodies for PCIs.
Conclusions
A scoping review was sufficient to capture recent trends in PCIs
designed to facilitate medical research. We identified 21 PCIs
currently operating in the United States, the United Kingdom,
and Japan. This review contributes to a better understanding of
the concept of active involvement by patients that can be
facilitated by PCIs, by clarifying the various modes of
communication and decision making. Although it is an emerging
initiative in medical research, PCIs have the potential to
facilitate fruitful collaboration between participants and
researchers.
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